CUBT (Curative Biotechnology) Total Stockholders Equity: $-17.91 Mil (As of Mar. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Curative Biotechnology Total Stockholders Equity?

Curative Biotechnology CUBT +17.00% Total Stockholders Equity is $-17.91 Mil as of Mar. 2023.

Curative Biotechnology's Total Stockholders Equity for the quarter that ended in Mar. 2023 was $-17.91 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Curative Biotechnology's Book Value per Share for the quarter that ended in Mar. 2023 was $-4.27. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Curative Biotechnology's Debt-to-Equity for the quarter that ended in Mar. 2023 was -0.08.

Curative Biotechnology  (OTCPK:CUBT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Curative Biotechnology's Book Value per Share for the quarter that ended in Mar. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-17.912-0)/4.193
=-4.27

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Curative Biotechnology's Debt-to-Equity for the quarter that ended in Mar. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.369 + 0) / -17.912
=-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biotechnology Total Stockholders Equity Related Terms

Curative Biotechnology Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Curative Biotechnology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biotechnology Total Stockholders Equity Chart

Curative Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Stockholders Equity
Get a 7-Day Free Trial -0.69 -0.36 -4.52 -16.36 -20.53

Curative Biotechnology Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.69 -17.98 -19.12 -20.53 -17.91
What does a Total Stockholders Equity of $-17.91 Mil mean?
Curative Biotechnology (CUBT) has a Total Stockholders Equity of $-17.91 Mil as of Mar. 2023. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Curative Biotechnology and its competitors.
Is Curative Biotechnology's Total Stockholders Equity too high?
Curative Biotechnology's current Total Stockholders Equity is $-17.91 Mil.
How does Curative Biotechnology's Total Stockholders Equity compare to ORGS and SNSE?
Curative Biotechnology's Total Stockholders Equity of $-17.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Curative Biotechnology and its competitors. Curative Biotechnology's current Total Stockholders Equity is $-17.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biotechnology stock overvalued right now?
Curative Biotechnology (CUBT) has a current Total Stockholders Equity of $-17.91 Mil. The current Total Stockholders Equity is $-17.91 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Curative Biotechnology (CUBT), the current Total Stockholders Equity is $-17.91 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biotechnology Business Description

Address 3801 PGA Boulevard, Suite 600, Palm Beach Gardens, FL, USA, 33410
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The Company is identifying, acquiring, and developing disease-modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech currently has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro-oncology. The Company is now concentrating its energy and resources on its degenerative eye disease platform.